ATAD2 and hepatocellular carcinoma: Lu et al. [44] analyzed the clinical pathological data of 75 HCC patients and correlated the overexpression of ATPase family AAA domain-containing protein 2 (ATAD2) with more aggressive phenotypes since significantly associated with high AFP levels, advanced tumor stages, and vascular invasion [44].